Compare MX & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MX | SEER |
|---|---|---|
| Founded | 2003 | 2017 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.4M | 97.3M |
| IPO Year | 2007 | 2020 |
| Metric | MX | SEER |
|---|---|---|
| Price | $2.87 | $1.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.75 | N/A |
| AVG Volume (30 Days) | ★ 278.6K | 223.6K |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.06 | 9.40 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $178,860,000.00 | $16,578,000.00 |
| Revenue This Year | $8.55 | $2.14 |
| Revenue Next Year | $6.37 | $25.90 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 16.99 |
| 52 Week Low | $2.18 | $1.64 |
| 52 Week High | $4.50 | $2.41 |
| Indicator | MX | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 52.32 | 42.31 |
| Support Level | $2.56 | $1.69 |
| Resistance Level | $3.02 | $1.97 |
| Average True Range (ATR) | 0.15 | 0.05 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 46.95 | 26.32 |
MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The company operates in two segments namely, Transitional Fab 3 foundry services and Standard products business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.